Compass Therapeutics, Inc. (CMPX)
2.52
+0.12
(+5.00%)
USD |
NASDAQ |
Aug 25, 16:00
2.50
-0.02
(-0.79%)
After-Hours: 19:59
Compass Therapeutics Market Cap : 453.82M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 432.21M |
| August 21, 2026 | 432.21M |
| August 20, 2026 | 425.01M |
| August 19, 2026 | 446.62M |
| August 18, 2026 | 430.41M |
| August 17, 2026 | 416.00M |
| August 14, 2026 | 405.20M |
| August 13, 2026 | 407.00M |
| August 12, 2026 | 426.81M |
| August 11, 2026 | 396.19M |
| August 10, 2026 | 399.80M |
| August 07, 2026 | 387.19M |
| August 06, 2026 | 358.38M |
| August 05, 2026 | 340.37M |
| August 04, 2026 | 356.57M |
| August 03, 2026 | 339.47M |
| July 31, 2026 | 343.97M |
| July 30, 2026 | 349.37M |
| July 29, 2026 | 349.37M |
| July 28, 2026 | 367.38M |
| July 27, 2026 | 374.58M |
| July 24, 2026 | 372.78M |
| July 23, 2026 | 381.79M |
| July 22, 2026 | 367.38M |
| July 21, 2026 | 378.18M |
| Date | Value |
|---|---|
| July 20, 2026 | 363.78M |
| July 17, 2026 | 369.18M |
| July 16, 2026 | 378.18M |
| July 15, 2026 | 385.39M |
| July 14, 2026 | 394.39M |
| July 13, 2026 | 407.00M |
| July 10, 2026 | 419.60M |
| July 09, 2026 | 416.00M |
| July 08, 2026 | 421.41M |
| July 07, 2026 | 417.80M |
| July 06, 2026 | 412.40M |
| July 02, 2026 | 408.80M |
| July 01, 2026 | 392.59M |
| June 30, 2026 | 394.39M |
| June 29, 2026 | 388.99M |
| June 26, 2026 | 374.58M |
| June 25, 2026 | 372.78M |
| June 24, 2026 | 363.78M |
| June 23, 2026 | 370.98M |
| June 22, 2026 | 378.18M |
| June 18, 2026 | 363.78M |
| June 17, 2026 | 369.18M |
| June 16, 2026 | 354.77M |
| June 15, 2026 | 367.38M |
| June 12, 2026 | 365.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Upstream Bio, Inc. | 393.26M |
| ACADIA Pharmaceuticals, Inc. | 5.264B |
| Alnylam Pharmaceuticals, Inc. | 32.09B |
| Anika Therapeutics, Inc. | 288.00M |
| Savara, Inc. | 1.148B |
Market Cap Related Metrics
| Price to Book Value | 2.733 |
| Price | 2.52 |
| Earnings Yield | -15.97% |